Actively Recruiting
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
Led by Xiujuan Zang · Updated on 2025-07-11
1890
Participants Needed
1
Research Sites
22 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are: 1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting? 2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters. Participants will: 1. Provide blood samples for POCT and laboratory testing. 2. Participate in interviews or questionnaires to gather clinical and lifestyle information. The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.
CONDITIONS
Official Title
Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older with stable vital signs, including body temperature between 36.0°C and 38.0°C, pulse 50-120 beats/min, respiratory rate 10-24 breaths/min, and blood pressure with systolic ≥90 mmHg and diastolic ≥60 mmHg
- Willing to participate and able to sign informed consent
- Hematocrit (Hct) level between 25% and 60%
- Confirmed diagnosis of chronic kidney disease (CKD)
You will not qualify if you...
- In unstable phase of acute cardiovascular or cerebrovascular diseases such as acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome
- In unstable phase of severe acute diabetic complications like diabetic ketoacidosis or hyperosmolar hyperglycemic coma
- Currently in acute kidney injury (AKI) stage
- Receiving renal replacement therapy
- Pregnant or breastfeeding
- Participated in other clinical trials within the last six months
- Unable to understand verbal or written instructions including informed consent
- Unable to cooperate with study procedures
- Other conditions deemed unsuitable by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200025
Actively Recruiting
Research Team
X
Xiujuan Zang, MD
CONTACT
X
Xiangyu Zhang, MMed
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here